Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Galva Technologies Tbk. (GLVA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Galva Technologies Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Galva Technologies Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Galva Technologies Tbk. trades at Rp312 (market cap 468B, 67.7K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Galva Technologies Tbk. is far larger — about 2.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (187.4K versus 67.7K). Which is the better fit depends on your goals.

GLVAOBAT
Market Cap
468B164.65B
Volume
67.7K187.4K
Lot
6771.87K
Turnover
20.95M44.35M
Average Price
309.49236.67
Value
20.95M44.35M
Indicative Equilibrium Price
312242
Indicative Equilibrium Volume
14500

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GLVA
View details
OBAT
View details

About Galva Technologies Tbk.

PT Galva Technologies Tbk (the “Company”) was established under the Deed No. 1 dated September 1, 1991 by notary Fransiscus Jacobus Mawati, S.H., notary in Jakarta.

Read more on GLVA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT